Ornidazole Dispersible Tablets

Ornidazole is a third-generation nitroimidazole antimicrobial drug. The main mechanism of action of Ornidazole is that the nitro group in its molecule is reduced to an amino group in an anaerobic environment or through the formation of free radicals, which interacts with cell components and causes the death of microorganisms.

Ornidazole.

This product is off-white or slightly yellow tablets.

This product is suitable for infections caused by sensitive protozoa and anaerobic bacteria: 1. For male and female urogenital tract infections caused by Trichomonas; 2. For intestinal and hepatic amoebiasis caused by amoeba (including amoebic dysentery and amoebic liver abscess); 3. For giardiasis; 4. For anaerobic infections: such as sepsis, meningitis, peritonitis, postoperative wound infection, postpartum sepsis, septic abortion, endometritis and other infections caused by sensitive bacteria; 5. For the prevention of various postoperative anaerobic infections.

1-2 times/day; 1 capsule/1 time.

1. Mild side effects such as drowsiness, headache, gastrointestinal discomfort (including nausea and vomiting) may be seen. 2. Some patients may experience central nervous system disorders such as headache, tremor, rigidity, epileptic seizures, movement disorders, fatigue, dizziness, temporary loss of consciousness or peripheral neuropathy. 3. Taste disorders, abnormal liver function and skin reactions.

Patients who are allergic to this product or nitroimidazole drugs are contraindicated.

Precautions for children: For children weighing more than 6 kg, the dosage should be strictly in accordance with the doctor's prescription and the child's weight. Precautions for pregnancy and lactation: Use with caution in early pregnancy; breastfeeding is not suitable during treatment. Precautions for the elderly: Reduce the dosage as directed by the doctor.

1. Ornidazole can enhance the effect of coumarin oral anticoagulants, so when the two are used at the same time, the dose of the anticoagulant should be adjusted. 2. Ornidazole can prolong the muscle relaxant effect of vecuronium bromide, reduce its efficacy and affect coagulation. 3. Barbiturates, ranitidine, and cimetidine can accelerate the elimination of ornidazole, so they should be avoided when used together with ornidazole.

Sealed and stored away from light.

0.25 g (calculated as C7H10ClN3O3)

24 months

Hunan Jiudian Pharmaceutical Co., Ltd.

• Founded in:

  2001-01-19

• Address:

  No. 1 Jiankang Avenue, Liuyang Economic and Technological Development Zone, Changsha

• Tax NO.:

  91430100722520761D

• Registered Funds:

  345.145427 yuan

• Website:

  Log in to view

• Email:

  Log in to view